Waqas Ahmed: Iron-Enriched Yeast Offers a New Approach to Iron Deficiency
Waqas Ahmed, Associate Professor at University of Veterinary and Animal Sciences in Pakistan, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Scientific Reports, adding:
”Anemia is among one of the most prevalent micronutrient deficiencies. One of the most common forms of anemia is iron deficiency anemia. Oral iron supplements are mainly used to treat iron deficiency but pose a few side effects such as gastrointestinal problems, poor compliance and dietary restrictions. Iron-enriched yeast Saccharomyces cerevisiae has been shown to increase iron bioavailability as it is converted into organic form making it more absorbable as compared to conventional iron supplements.
Glad to share recent research from one of my MPhil student is published in Scientific Reports. It was something new to be executed in UVAS.
I am grateful to my colleagues Dr. Azmat Ullah Khan and Professor Muhammad Nawaz sahb for kind support and cooperation in the matter.”
Title: Effect of iron enriched yeast saccharomyces cerevisiae on iron status of anemic rats
Authors: Ureeba Rauf, Waqas Ahmed, Azmat Ullah, Muhammad Nawaz, Abdul Momin Rizwan Ahmad, Nilab Mohammadi

Stay updated with Hemostasis Today.
-
Aug 16, 2026, 16:05Bhaskar M.: Blood Bank – The Lifeline of Modern Healthcare
-
Aug 16, 2026, 15:54Oliver Weingärtner: The Care Transition Gap – Why LDL-C Control Is Lost After STEMI
-
Aug 16, 2026, 15:45Gloria Duah: Why Clinical Information Matters When Requesting Blood
-
Aug 16, 2026, 15:42Emmanuel J Favaloro: Latest Collaborative Publication From the Sydney Centres for Thrombosis and Haemostasis
-
Aug 16, 2026, 15:11Grace Yau: Inhalable Platelet Lysate Opens New Possibilities for Pulmonary Therapy
-
Aug 16, 2026, 14:52Connie Montgomery: Enjoyed My Opportunity to Facilitate and Speak at BDC 2026
-
Aug 16, 2026, 14:47Targeted Outside-In Signaling Inhibition – Dissociating Thrombosis from Hemostasis – JTH
-
Aug 16, 2026, 14:38Christopher Hanson: Broad-Spectrum Platelet Inhibition via Non-Odorant OR2L13 Agonists
-
Aug 16, 2026, 14:27Preeti Verma: The Case of the Missing Clue – Why Databases Need a Clinician’s Eye